SPCC23B6.04c Antibody

What is SPCC23B6.04c Antibody and what specific target does it recognize?

SPCC23B6.04c Antibody is a polyclonal antibody raised in rabbits that specifically targets the SPCC23B6.04c protein from Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast. The antibody was developed using a recombinant SPCC23B6.04c protein as the immunogen. This antibody corresponds to the UniProt accession number Q9UU99 and is classified as an IgG isotype . As a research tool, this antibody is intended for experimental applications only and not for diagnostic or therapeutic purposes. The antibody is purified using antigen affinity methods to enhance its specificity and reduce background noise in experimental applications.

What optimal storage conditions ensure SPCC23B6.04c Antibody stability?

For SPCC23B6.04c Antibody, optimal storage requires maintaining the antibody at either -20°C or -80°C upon receipt. It is critical to avoid repeated freeze-thaw cycles, as these can significantly degrade antibody performance through protein denaturation and aggregation . The antibody is supplied in liquid form with a storage buffer containing 0.03% Proclin 300 as a preservative and 50% glycerol in 0.01M PBS at pH 7.4 . The glycerol component serves as a cryoprotectant that helps maintain antibody stability during freezing. For short-term use, small aliquots can be prepared to minimize freeze-thaw cycles. When working with the antibody, it should be handled on ice and returned to storage promptly after use.

What applications has SPCC23B6.04c Antibody been validated for?

SPCC23B6.04c Antibody has been specifically validated for Western Blotting (WB) and Enzyme-Linked Immunosorbent Assay (ELISA) applications . When using this antibody for WB, researchers should ensure proper identification of the antigen through appropriate controls. The antibody's validation for these specific applications aligns with best practices in the field, which emphasize that antibodies should be validated in an application-specific manner due to conformational changes in antigens between different techniques . For instance, in Western blotting, proteins are typically denatured, exposing epitopes that might be hidden in native conformations, while ELISA often works with proteins in their more native state.

How should researchers document SPCC23B6.04c Antibody characteristics for publication?

For publication purposes, researchers should comprehensively document the following information about SPCC23B6.04c Antibody:

This documentation approach follows recommendations from antibody validation guidelines that emphasize transparency and reproducibility in antibody-based research .

What validation strategies should be employed to confirm SPCC23B6.04c Antibody specificity?

Validation of SPCC23B6.04c Antibody should follow the established "Five Pillars" approach recommended by antibody validation guidelines:

• Genetic Validation: Test the antibody in S. pombe cells where SPCC23B6.04c has been knocked out or significantly downregulated. The absence or reduction of signal confirms specificity .

• Orthogonal Validation: Compare protein expression detected by the antibody with an orthogonal method that doesn't use antibodies, such as mass spectrometry or RNA-seq, to verify consistent expression patterns .

• Independent Antibody Validation: Use at least two different antibodies targeting different epitopes of SPCC23B6.04c and compare the resulting patterns .

• Expression Validation: Test the antibody across different strains or conditions where SPCC23B6.04c expression is expected to vary, confirming that signal intensity correlates with expected expression levels .

• Immunocapture Mass Spectrometry: Perform immunoprecipitation followed by mass spectrometry to sequence captured proteins. For high specificity, the top three peptide sequences should all be from SPCC23B6.04c .

For SPCC23B6.04c Antibody specifically, researchers should at minimum perform application-specific validation for the intended use in ELISA or Western blotting, as these are the applications for which this antibody has been tested .

How should researchers determine the optimal concentration of SPCC23B6.04c Antibody?

Determining the optimal concentration of SPCC23B6.04c Antibody requires systematic titration experiments that evaluate both signal-to-noise ratio and dynamic range. This methodological approach is critical because using too much antibody can yield nonspecific results, while too little can lead to false-negative results .

For Western blotting applications:

• Prepare a dilution series of SPCC23B6.04c Antibody (e.g., 1:500, 1:1000, 1:2000, 1:5000, 1:10000)

• Use identical protein samples and blotting conditions for each dilution

• Quantify both specific signal (target band) and non-specific background

• Calculate signal-to-noise ratio for each dilution

• Select the concentration that provides the highest signal-to-noise ratio while maintaining sufficient signal intensity

For ELISA applications:

• Create an antibody dilution series in a checkerboard titration against varying concentrations of target antigen

• Include appropriate negative controls (absence of antigen or primary antibody)

• Measure absorbance values and generate binding curves

• Identify the antibody concentration that provides optimal discrimination between positive and negative samples

• Confirm linearity within the desired detection range

The optimal working concentration should be established independently for each application and experimental condition .

What essential controls should be included when using SPCC23B6.04c Antibody?

When conducting experiments with SPCC23B6.04c Antibody, researchers should implement a comprehensive set of controls to ensure data reliability and specificity:

These controls should be run simultaneously with experimental samples under identical conditions. For Western blotting specifically, loading controls (e.g., housekeeping proteins) should be included to normalize protein loading across lanes .

What are the optimal sample preparation protocols for Western blotting with SPCC23B6.04c Antibody?

For effective Western blotting using SPCC23B6.04c Antibody in S. pombe studies, follow this methodological workflow:

• Cell Lysis and Protein Extraction:

  • Harvest S. pombe cells in mid-logarithmic growth phase

  • Wash cells in ice-cold PBS to remove media components

  • Lyse cells using glass bead disruption in lysis buffer containing protease inhibitors

  • Centrifuge lysate at 14,000 × g for 10 minutes to remove cell debris

  • Quantify protein concentration using Bradford or BCA assay

• Sample Preparation:

  • Prepare samples containing 20-50 μg total protein

  • Add reducing sample buffer containing SDS and DTT

  • Heat samples at a moderate temperature (70°C for 10 minutes) to minimize aggregation

  • Include molecular weight markers to identify target protein (~molecular weight of SPCC23B6.04c)

• Gel Electrophoresis and Transfer:

  • Use 10-12% SDS-PAGE gels for optimal resolution of the target protein

  • Transfer proteins to PVDF or nitrocellulose membrane at 100V for 60-90 minutes

  • Verify transfer efficiency using reversible protein staining (Ponceau S)

• Immunodetection Protocol:

  • Block membrane with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

  • Incubate with optimized dilution of SPCC23B6.04c Antibody overnight at 4°C

  • Wash membrane 4-5 times with TBST, 5 minutes each

  • Incubate with appropriate HRP-conjugated secondary antibody for 1 hour at room temperature

  • Wash thoroughly and develop using enhanced chemiluminescence

This protocol incorporates best practices for antibody-based Western blotting while considering the specific characteristics of SPCC23B6.04c Antibody as a rabbit polyclonal against a yeast protein .

How can researchers optimize ELISA protocols for SPCC23B6.04c Antibody?

Optimizing ELISA protocols for SPCC23B6.04c Antibody requires attention to multiple parameters:

• Coating Conditions:

  • For direct ELISA: Coat plates with purified recombinant SPCC23B6.04c protein (1-10 μg/ml) in carbonate buffer (pH 9.6)

  • For sandwich ELISA: Use a capture antibody against a different epitope of SPCC23B6.04c

  • Incubate coated plates overnight at 4°C

  • Wash with PBS containing 0.05% Tween-20 (PBST)

• Blocking Parameters:

  • Block with 1-3% BSA in PBS for 1-2 hours at room temperature

  • Alternative: Use 5% non-fat dry milk in PBS

  • Optimize blocking to minimize background without reducing specific signal

• Antibody Incubation:

  • Titrate SPCC23B6.04c Antibody concentrations (starting with 1:1000 dilution)

  • Incubate for 1-2 hours at room temperature or overnight at 4°C

  • Maintain constant antibody diluent composition (typically 1% BSA in PBST)

• Detection System:

  • Use HRP-conjugated anti-rabbit secondary antibody

  • Develop with TMB substrate and measure absorbance at 450 nm

  • Consider amplification systems for low-abundance targets

• Assay Validation Parameters:

  • Determine detection limit, working range, and reproducibility

  • Evaluate precision through intra- and inter-assay CV calculations

  • Assess specificity through competitive inhibition experiments

Researchers should systematically optimize each parameter while keeping other conditions constant to identify the optimal ELISA configuration for SPCC23B6.04c detection .

What troubleshooting approaches should be used when SPCC23B6.04c Antibody fails to detect target protein?

When SPCC23B6.04c Antibody fails to detect the target protein, implement this systematic troubleshooting strategy:

If standard troubleshooting fails, consider switching applications (e.g., from Western blot to ELISA) or obtaining additional validation data using orthogonal methods to confirm antibody performance .

How can researchers evaluate SPCC23B6.04c Antibody cross-reactivity in complex biological systems?

Evaluating cross-reactivity of SPCC23B6.04c Antibody in complex biological systems requires a multi-faceted approach:

• Comparative Proteomics Analysis:

  • Conduct Western blotting across different species with varying evolutionary distances from S. pombe

  • Analyze patterns of detected bands to identify potential cross-reactive proteins

  • Use mass spectrometry to identify any off-target proteins detected by the antibody

• Epitope Analysis and Competitive Binding:

  • Perform epitope mapping to identify the specific sequence recognized by SPCC23B6.04c Antibody

  • Use BLAST analysis to identify proteins with similar epitope sequences

  • Conduct competitive binding assays with synthetic peptides corresponding to potential cross-reactive epitopes

• Immunodepletion Studies:

  • Pre-adsorb SPCC23B6.04c Antibody with recombinant target protein

  • Compare signal patterns before and after depletion

  • Residual signal after complete depletion indicates cross-reactivity

• Immunocapture Mass Spectrometry Validation:

  • Perform immunoprecipitation with SPCC23B6.04c Antibody

  • Analyze captured proteins by mass spectrometry

  • Rank identified proteins by peptide abundance

  • For high specificity, the top three peptide sequences should all be from SPCC23B6.04c

• Genetic Validation in Model Systems:

  • Test antibody reactivity in wild-type versus SPCC23B6.04c knockout S. pombe

  • Examine signal intensity in cells with varying expression levels of SPCC23B6.04c

  • Investigate heterologous expression systems expressing only SPCC23B6.04c

This comprehensive approach provides multiple lines of evidence regarding antibody specificity and potential cross-reactivity, essential for accurate interpretation of experimental results .

What strategies can optimize signal-to-noise ratio when using SPCC23B6.04c Antibody in challenging samples?

Optimizing signal-to-noise ratio for SPCC23B6.04c Antibody in challenging samples requires attention to multiple experimental parameters:

• Sample Preparation Refinements:

  • Implement differential centrifugation to enrich for specific subcellular fractions

  • Use more selective extraction buffers to reduce co-extracting proteins

  • Consider native versus denaturing conditions based on epitope accessibility

  • For difficult samples, test different detergents (CHAPS, NP-40, Triton X-100)

• Signal Amplification Technologies:

  • Implement tyramide signal amplification (TSA) for immunohistochemistry applications

  • Use high-sensitivity detection systems (enhanced chemiluminescence plus)

  • Consider biotin-streptavidin amplification systems

  • For fluorescence applications, utilize photon-counting or spectral unmixing

• Background Reduction Techniques:

  • Pre-adsorb antibody with proteins from non-target species

  • Implement dual-blocking strategies (e.g., BSA followed by normal serum)

  • Increase washing stringency (higher salt concentration, longer wash times)

  • Use low-fluorescence or low-binding materials to reduce non-specific adsorption

• Antibody Purification Approaches:

  • Consider affinity purification against recombinant SPCC23B6.04c protein

  • Use negative selection against known cross-reactive proteins

  • Implement IgG purification to remove non-specific immunoglobulins

• Image Analysis and Quantification:

  • Implement local background subtraction algorithms

  • Use ratio imaging when applicable

  • Consider deconvolution algorithms for microscopy applications

  • Implement machine learning approaches for automated signal/noise discrimination

These strategies should be systematically tested and optimized for the specific experimental context, considering that the SPCC23B6.04c Antibody is a rabbit polyclonal that may have batch-to-batch variation .

How should researchers interpret conflicting results when using SPCC23B6.04c Antibody across different experimental platforms?

When researchers encounter conflicting results using SPCC23B6.04c Antibody across different experimental platforms, they should implement the following analytical framework:

• Systematic Comparison of Experimental Conditions:

  • Create a detailed matrix comparing all experimental variables between platforms

  • Focus on buffer compositions, sample preparation methods, and detection systems

  • Identify critical differences that might affect epitope accessibility or antibody binding

• Epitope Conformation Analysis:

  • Assess whether the target epitope maintains its structure across different conditions

  • Consider that SPCC23B6.04c Antibody may recognize linear epitopes (effective for WB) versus conformational epitopes (for ELISA)

  • Test mild versus harsh denaturing conditions to evaluate epitope sensitivity

• Validation Through Orthogonal Methods:

  • Implement non-antibody-based detection methods (e.g., mass spectrometry)

  • Use genetic approaches (knockout, knockdown) to confirm specificity

  • Consider alternative antibodies against the same target but different epitopes

• Statistical Analysis of Reproducibility:

  • Quantify variability within and between experimental platforms

  • Implement statistical tests to determine if differences are significant

  • Calculate confidence intervals for measurements across platforms

• Biological Context Integration:

  • Consider whether conflicting results reflect actual biological differences

  • Examine whether sample heterogeneity might explain divergent results

  • Evaluate if post-translational modifications affect antibody recognition in different contexts

• Decision Framework for Data Interpretation:

This structured approach enables researchers to systematically evaluate conflicting results and derive meaningful biological interpretations despite technical variations .

What approaches can assess batch-to-batch variability of SPCC23B6.04c Antibody for longitudinal studies?

For longitudinal studies using SPCC23B6.04c Antibody, researchers must implement robust strategies to assess and mitigate batch-to-batch variability:

• Reference Sample Standardization:

  • Create a large batch of reference S. pombe lysate aliquots stored at -80°C

  • Test each new antibody batch against the same reference samples

  • Generate standard curves for quantitative applications

  • Calculate correction factors to normalize between batches if necessary

• Critical Quality Attribute (CQA) Assessment:

  • Measure key performance indicators for each batch:

    • Specific signal intensity at standardized concentration

    • Background signal under identical conditions

    • Signal-to-noise ratio

    • EC50/IC50 values for binding assays

    • Band pattern consistency in Western blotting

• Epitope-Specific Validation:

  • Perform competitive binding assays with synthetic peptides

  • Compare epitope recognition profiles between batches

  • Assess binding kinetics using surface plasmon resonance if available

• Internal Controls and Normalization Strategy:

  • Include identical internal controls in all experiments

  • Develop a normalization algorithm based on control sample results

  • Implement statistical methods to correct for batch effects

  • Consider multiplex approaches with invariant reference proteins

• Comprehensive Documentation System:

  • Create detailed records of batch performance characteristics

  • Document specific applications validated for each batch

  • Maintain searchable database of experimental conditions and outcomes

  • Implement version control for protocols optimized for specific batches

This systematic approach enables researchers to maintain data integrity across long-term studies despite the inherent variability of polyclonal antibodies like SPCC23B6.04c Antibody .

How can SPCC23B6.04c Antibody be adapted for super-resolution microscopy applications?

Although SPCC23B6.04c Antibody is primarily validated for Western blotting and ELISA applications , researchers can adapt it for super-resolution microscopy through several methodological approaches:

• Secondary Antibody Optimization:

  • Select secondary antibodies conjugated to bright, photostable fluorophores (e.g., Alexa Fluor 647)

  • For STORM/PALM: Use secondary antibodies with appropriate blinking characteristics

  • For STED: Choose fluorophores with high depletion efficiency

  • Consider using F(ab')2 fragments to reduce distance between fluorophore and epitope

• Sample Preparation Refinements:

  • Implement optimized fixation protocols to preserve cellular ultrastructure

  • Test different fixatives (paraformaldehyde, glutaraldehyde, methanol) for epitope preservation

  • Use permeabilization conditions that maintain cellular architecture

  • For S. pombe, optimize cell wall digestion conditions for antibody accessibility

• Signal Amplification and Background Reduction:

  • Implement click chemistry approaches for signal amplification

  • Use quantum dots for improved photostability

  • Apply specialized mounting media to reduce background and enhance photostability

  • Consider expansion microscopy to physically magnify specimens

• Validation Controls for Microscopy:

  • Perform z-stack imaging to confirm signal throughout cell depth

  • Include no-primary antibody controls to assess non-specific binding

  • Use SPCC23B6.04c knockout S. pombe as negative control

  • Compare localization patterns with GFP-tagged SPCC23B6.04c constructs

• Quantitative Analysis Approaches:

  • Implement cluster analysis algorithms appropriate for the super-resolution technique

  • Use nearest neighbor analysis to examine protein distribution patterns

  • Perform colocalization analysis with known organelle markers

  • Consider machine learning approaches for automated pattern recognition

This adaptation requires careful validation given that SPCC23B6.04c Antibody was not originally validated for immunofluorescence applications .

What considerations are important when combining SPCC23B6.04c Antibody detection with proteomic approaches?

When integrating SPCC23B6.04c Antibody with proteomic analyses, researchers should address these methodological considerations:

• Immunoprecipitation Optimization for Mass Spectrometry:

  • Select IP buffers compatible with downstream MS analysis

  • Optimize antibody-to-sample ratio to maximize target capture

  • Implement stringent washing protocols to reduce non-specific binding

  • Consider crosslinking antibody to beads to prevent antibody contamination in MS samples

• Identification of Protein Interaction Networks:

  • Compare SPCC23B6.04c immunoprecipitates with control IgG to identify specific interactors

  • Implement quantitative approaches (SILAC, TMT) to rank interaction confidence

  • Use mild detergents to preserve weak or transient interactions

  • Consider proximity labeling approaches (BioID, APEX) as complementary methods

• Antibody-Based Protein Quantification:

  • Calibrate antibody-based quantification against MS-derived absolute quantification

  • Develop correction factors for potential epitope masking in complex samples

  • Implement internal standards for normalization across multiple samples

  • Consider the dynamic range limitations of both antibody and MS detection

• Cross-Validation Strategy:

  • Confirm MS-identified SPCC23B6.04c interactors by reciprocal co-immunoprecipitation

  • Validate MS-detected post-translational modifications using modification-specific antibodies

  • Correlate MS-based and antibody-based quantification for method validation

  • Implement orthogonal approaches to confirm key findings

• Data Integration Framework:

  • Develop computational pipelines to integrate antibody-based and MS-based datasets

  • Implement appropriate statistical methods for multi-omic data analysis

  • Consider machine learning approaches for pattern recognition across datasets

  • Develop visualization tools to represent integrated datasets effectively

This integrated approach leverages the specificity of SPCC23B6.04c Antibody with the comprehensive analysis capabilities of mass spectrometry-based proteomics .

What steps are required to develop a quantitative ELISA using SPCC23B6.04c Antibody?

Developing a reliable quantitative ELISA using SPCC23B6.04c Antibody requires a systematic methodological approach:

• Assay Design and Component Selection:

  • Determine optimal assay format (direct, indirect, sandwich, competitive)

  • For sandwich ELISA, source a second antibody recognizing a different SPCC23B6.04c epitope

  • Select appropriate plate type (high-binding for direct, medium-binding for sandwich)

  • Choose detection system based on sensitivity requirements (colorimetric, fluorescent, chemiluminescent)

• Reagent Optimization:

  • Determine optimal coating concentration of capture antibody or antigen

  • Optimize SPCC23B6.04c Antibody dilution through checkerboard titration

  • Test different blocking agents (BSA, casein, normal serum) for minimal background

  • Evaluate detection antibody concentration and incubation conditions

• Standard Curve Development:

  • Prepare purified recombinant SPCC23B6.04c protein as calibrator

  • Generate standard curve covering at least 2-3 logs of concentration

  • Evaluate different curve-fitting models (4PL, 5PL) for best fit

  • Determine lower and upper limits of quantification (LLOQ, ULOQ)

• Analytical Validation Parameters:

• Sample-Specific Validation:

  • Evaluate matrix effects from different sample types

  • Develop sample dilution protocols to minimize interference

  • Establish sample stability conditions and acceptable freeze-thaw cycles

  • Create appropriate quality control samples mirroring expected concentrations

This comprehensive development and validation approach ensures a reliable quantitative ELISA for SPCC23B6.04c detection in research applications .

How can researchers combine genetic manipulation of S. pombe with SPCC23B6.04c Antibody studies?

Integrating genetic manipulation of S. pombe with SPCC23B6.04c Antibody studies creates powerful experimental systems:

• Genetic Knockout Validation Strategy:

  • Create SPCC23B6.04c deletion strains using homologous recombination

  • Use CRISPR-Cas9 for precise gene editing of SPCC23B6.04c

  • Implement auxin-inducible degron systems for controlled protein depletion

  • Compare antibody signal in wild-type versus knockout strains to confirm specificity

• Epitope Tagging Approaches:

  • Generate strains with epitope-tagged SPCC23B6.04c (FLAG, HA, V5)

  • Create a series of truncation mutants to map antibody recognition sites

  • Use dual detection (anti-tag + SPCC23B6.04c Antibody) to confirm specificity

  • Evaluate whether tags affect antibody recognition or protein function

• Expression Modulation Systems:

  • Construct strains with SPCC23B6.04c under inducible promoters

  • Implement repressible promoters for controlled downregulation

  • Create overexpression strains to evaluate antibody linearity at high concentrations

  • Use these strains to calibrate antibody detection across expression ranges

• Mutation Analysis Framework:

  • Generate point mutations in key functional domains

  • Create phosphomimetic or phospho-dead mutations at regulatory sites

  • Evaluate antibody detection of mutant forms

  • Correlate structural changes with epitope recognition patterns

• Experimental Design for Integrated Studies:

This integrated approach provides multiple levels of validation while enabling sophisticated studies of SPCC23B6.04c function and regulation .

What emerging technologies might enhance SPCC23B6.04c Antibody applications in the future?

The future of SPCC23B6.04c Antibody applications will likely be transformed by several emerging technologies:

• Single-Cell Antibody-Based Proteomics:

  • Integration with microfluidic platforms for single-cell resolution

  • Development of highly multiplexed detection systems using DNA-barcoded antibodies

  • Spatial proteomics approaches combining antibody detection with cellular imaging

  • Single-cell Western blotting techniques for heterogeneity analysis

• Advanced Structural Biology Integration:

  • Cryo-electron microscopy visualization of antibody-antigen complexes

  • Hydrogen-deuterium exchange mass spectrometry for epitope mapping

  • Integration with AlphaFold or similar structural prediction tools

  • Correlative light and electron microscopy for ultrastructural localization

• Antibody Engineering Advances:

  • Development of recombinant antibody fragments with enhanced specificity

  • Creation of bispecific antibodies for simultaneous detection of SPCC23B6.04c and interacting partners

  • Implementation of nanobody technology for improved penetration and reduced background

  • Site-specific conjugation strategies for optimal fluorophore positioning

• Artificial Intelligence Applications:

  • Machine learning algorithms for automated pattern recognition in antibody staining

  • Deep learning approaches for distinguishing specific from non-specific signals

  • AI-driven experimental design optimization

  • Computational approaches to predict epitope recognition across different conditions

• In Situ Proximity Detection:

  • Integration with proximity ligation assays for protein-protein interaction studies

  • Development of split-protein complementation systems triggered by antibody binding

  • In situ sequencing technologies for spatial mapping of SPCC23B6.04c interactions

  • CRISPR-based tagging systems for live-cell tracking of antibody targets